HU199476B - Process for producing benzopyrano /and -thiopyrano/ pyridines and pharmaceutical compositions comprising such compounds - Google Patents
Process for producing benzopyrano /and -thiopyrano/ pyridines and pharmaceutical compositions comprising such compounds Download PDFInfo
- Publication number
- HU199476B HU199476B HU851751A HU175185A HU199476B HU 199476 B HU199476 B HU 199476B HU 851751 A HU851751 A HU 851751A HU 175185 A HU175185 A HU 175185A HU 199476 B HU199476 B HU 199476B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- alkyl
- compound
- ring
- hydroxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 193
- 238000000034 method Methods 0.000 title claims description 64
- 230000008569 process Effects 0.000 title claims description 40
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 9
- 150000003222 pyridines Chemical class 0.000 title 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 45
- 125000004423 acyloxy group Chemical group 0.000 claims abstract description 21
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 19
- 239000001301 oxygen Substances 0.000 claims abstract description 17
- 150000002367 halogens Chemical class 0.000 claims abstract description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 13
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims description 59
- 239000000243 solution Substances 0.000 claims description 53
- -1 hydroxy, hydroxy Chemical group 0.000 claims description 46
- 239000000203 mixture Substances 0.000 claims description 46
- 125000001424 substituent group Chemical group 0.000 claims description 43
- 125000000217 alkyl group Chemical group 0.000 claims description 41
- 229910052739 hydrogen Inorganic materials 0.000 claims description 41
- 239000001257 hydrogen Substances 0.000 claims description 41
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 30
- 238000002360 preparation method Methods 0.000 claims description 29
- 239000007858 starting material Substances 0.000 claims description 29
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 24
- 150000002431 hydrogen Chemical class 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 239000003638 chemical reducing agent Substances 0.000 claims description 20
- 230000002829 reductive effect Effects 0.000 claims description 20
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 claims description 18
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 18
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 16
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 15
- 125000003545 alkoxy group Chemical group 0.000 claims description 14
- 229910052717 sulfur Chemical group 0.000 claims description 14
- 125000004043 oxo group Chemical group O=* 0.000 claims description 12
- 239000011593 sulfur Chemical group 0.000 claims description 12
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 10
- 125000000524 functional group Chemical group 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 7
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 6
- 230000000701 neuroleptic effect Effects 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims description 5
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
- 239000003176 neuroleptic agent Substances 0.000 claims description 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 4
- 230000001430 anti-depressive effect Effects 0.000 claims description 4
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 230000002452 interceptive effect Effects 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 3
- 125000001589 carboacyl group Chemical group 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 230000009257 reactivity Effects 0.000 claims description 3
- 239000000829 suppository Substances 0.000 claims description 3
- BJMSUUATNLDQQZ-DGCLKSJQSA-N (4as,10br)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-7-ol Chemical compound C1=CC=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1O BJMSUUATNLDQQZ-DGCLKSJQSA-N 0.000 claims description 2
- HBVFKJAKZKTZOB-BXKDBHETSA-N (4as,10br)-8-bromo-7-methoxy-4-methyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine Chemical compound C([C@@H]12)CCN(C)[C@@H]1COC1=C2C=CC(Br)=C1OC HBVFKJAKZKTZOB-BXKDBHETSA-N 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- 230000026030 halogenation Effects 0.000 claims description 2
- 238000005658 halogenation reaction Methods 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 238000009738 saturating Methods 0.000 claims description 2
- 125000003302 alkenyloxy group Chemical group 0.000 claims 2
- 238000005661 deetherification reaction Methods 0.000 claims 2
- 238000010511 deprotection reaction Methods 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 239000000314 lubricant Substances 0.000 claims 2
- 239000006187 pill Substances 0.000 claims 2
- 230000002195 synergetic effect Effects 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- HVJVYKLJJCMEFE-TZMCWYRMSA-N (4aS,10bR)-7-ethoxy-4,8-dimethyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine Chemical compound C(C)OC1=C(C=CC2=C1OC[C@H]1N(CCC[C@@H]12)C)C HVJVYKLJJCMEFE-TZMCWYRMSA-N 0.000 claims 1
- RVISITFMLATVSR-DGCLKSJQSA-N (4aS,10bR)-7-methoxy-4,8-dimethyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine Chemical compound C([C@@H]12)CCN(C)[C@@H]1COC1=C2C=CC(C)=C1OC RVISITFMLATVSR-DGCLKSJQSA-N 0.000 claims 1
- OOTZGPWBIFXGSV-TZMCWYRMSA-N (4aS,10bR)-8-ethyl-7-methoxy-4-methyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine Chemical compound C(C)C1=C(C2=C(C=C1)[C@@H]1[C@H](N(CCC1)C)CO2)OC OOTZGPWBIFXGSV-TZMCWYRMSA-N 0.000 claims 1
- UKQPRJSOSVDGII-NWDGAFQWSA-N (4as,10br)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-10-ol Chemical compound C1=CC(O)=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 UKQPRJSOSVDGII-NWDGAFQWSA-N 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 230000002152 alkylating effect Effects 0.000 claims 1
- 238000007075 allylic rearrangement reaction Methods 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 150000002513 isocyanates Chemical class 0.000 claims 1
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 abstract description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract description 4
- 125000004442 acylamino group Chemical group 0.000 abstract 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 78
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 49
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 46
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- 239000002904 solvent Substances 0.000 description 45
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 44
- 239000011541 reaction mixture Substances 0.000 description 42
- 239000000047 product Substances 0.000 description 35
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 30
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 27
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 26
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 22
- 238000007710 freezing Methods 0.000 description 21
- 230000008014 freezing Effects 0.000 description 21
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridine hydrochloride Substances [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 238000001035 drying Methods 0.000 description 18
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 18
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 18
- 235000019439 ethyl acetate Nutrition 0.000 description 15
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 15
- 235000019341 magnesium sulphate Nutrition 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- 239000002585 base Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- 238000010992 reflux Methods 0.000 description 13
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 12
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 12
- 230000009467 reduction Effects 0.000 description 12
- 238000006722 reduction reaction Methods 0.000 description 12
- 125000006239 protecting group Chemical group 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 10
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 10
- 230000003518 presynaptic effect Effects 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 239000000741 silica gel Substances 0.000 description 9
- 229910002027 silica gel Inorganic materials 0.000 description 9
- 108050004812 Dopamine receptor Proteins 0.000 description 8
- 102000015554 Dopamine receptor Human genes 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000012280 lithium aluminium hydride Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 description 6
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 241000124008 Mammalia Species 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 239000000556 agonist Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000012458 free base Substances 0.000 description 6
- 238000005984 hydrogenation reaction Methods 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 229940086542 triethylamine Drugs 0.000 description 6
- SHHLMGCHMMCOOS-UHFFFAOYSA-N 4h-chromen-3-one Chemical class C1=CC=C2CC(=O)COC2=C1 SHHLMGCHMMCOOS-UHFFFAOYSA-N 0.000 description 5
- KLYMTKVJYHTFIA-UHFFFAOYSA-N 4h-thiochromen-3-one Chemical class C1=CC=C2CC(=O)CSC2=C1 KLYMTKVJYHTFIA-UHFFFAOYSA-N 0.000 description 5
- 208000028017 Psychotic disease Diseases 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 230000001270 agonistic effect Effects 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000009833 condensation Methods 0.000 description 5
- 230000005494 condensation Effects 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 229960003638 dopamine Drugs 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 239000012442 inert solvent Substances 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000002798 polar solvent Substances 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 5
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 4
- KUNSCSSLJIBBFD-UHFFFAOYSA-N 6-methoxy-4h-chromen-3-one Chemical compound O1CC(=O)CC2=CC(OC)=CC=C21 KUNSCSSLJIBBFD-UHFFFAOYSA-N 0.000 description 4
- MNFVMLMDLUSEBS-UHFFFAOYSA-N 9-methoxy-4-propyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine Chemical compound C1=C(OC)C=C2C3=CCCN(CCC)C3COC2=C1 MNFVMLMDLUSEBS-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical class NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 4
- 239000003136 dopamine receptor stimulating agent Substances 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 229940057948 magnesium stearate Drugs 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 230000020477 pH reduction Effects 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000000159 protein binding assay Methods 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- ZELHQPRBSCZNHW-QMDUSEKHSA-N (4aS,10bR)-7-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.C1=CC=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1OC ZELHQPRBSCZNHW-QMDUSEKHSA-N 0.000 description 3
- CEVXGMUELSDOPY-LOCPCMAASA-N (4as,10br)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-7-ol;hydrochloride Chemical compound Cl.C1=CC=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1O CEVXGMUELSDOPY-LOCPCMAASA-N 0.000 description 3
- JFSZKRWNAVLJHH-QMDUSEKHSA-N (4as,10br)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-9-ol;hydrochloride Chemical compound Cl.C1=C(O)C=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 JFSZKRWNAVLJHH-QMDUSEKHSA-N 0.000 description 3
- JBWLMIOJPWLYPQ-IAGOWNOFSA-N (4as,10br)-9-methoxy-10b-methyl-4-propyl-4a,5-dihydro-3h-chromeno[3,4-b]pyridine Chemical compound C1=C(OC)C=C2[C@@]3(C)C=CCN(CCC)[C@@H]3COC2=C1 JBWLMIOJPWLYPQ-IAGOWNOFSA-N 0.000 description 3
- ASXGAOFCKGHGMF-UHFFFAOYSA-N 6-amino-5,6,7,8-tetrahydronaphthalene-2,3-diol Chemical compound OC1=C(O)C=C2CC(N)CCC2=C1 ASXGAOFCKGHGMF-UHFFFAOYSA-N 0.000 description 3
- HHEBBHNRCWBWFR-UHFFFAOYSA-N 8-methoxy-4h-chromen-3-one Chemical compound C1C(=O)COC2=C1C=CC=C2OC HHEBBHNRCWBWFR-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 3
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 description 3
- 150000002081 enamines Chemical class 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229960004502 levodopa Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical class OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 3
- 230000000506 psychotropic effect Effects 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000015424 sodium Nutrition 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- GVYVVBLXRIENDX-PSASIEDQSA-N (3r,4r)-3-bromo-6-methoxy-3,4-dihydro-2h-chromen-4-ol Chemical compound O1C[C@@H](Br)[C@H](O)C2=CC(OC)=CC=C21 GVYVVBLXRIENDX-PSASIEDQSA-N 0.000 description 2
- CXGQRIUDJGHMQS-MWLCHTKSSA-N (4as,10br)-4-methyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-7-ol Chemical compound C1=CC=C2[C@H]3CCCN(C)[C@@H]3COC2=C1O CXGQRIUDJGHMQS-MWLCHTKSSA-N 0.000 description 2
- GFCDMVGEDLAHIF-ZYHUDNBSSA-N (4as,10br)-7-methoxy-4-methyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine Chemical compound C([C@@H]12)CCN(C)[C@@H]1COC1=C2C=CC=C1OC GFCDMVGEDLAHIF-ZYHUDNBSSA-N 0.000 description 2
- BYTDMYLHLQZNGX-UKRRQHHQSA-N (4as,10br)-9-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine Chemical compound C1=C(OC)C=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 BYTDMYLHLQZNGX-UKRRQHHQSA-N 0.000 description 2
- LTKBXXKVCVHLMI-SWYZXDRTSA-N (4as,10br)-9-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C1=C(OC)C=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 LTKBXXKVCVHLMI-SWYZXDRTSA-N 0.000 description 2
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 2
- OCQAXYHNMWVLRH-UHFFFAOYSA-N 2,3-dibenzoyl-2,3-dihydroxybutanedioic acid Chemical class C=1C=CC=CC=1C(=O)C(O)(C(O)=O)C(O)(C(=O)O)C(=O)C1=CC=CC=C1 OCQAXYHNMWVLRH-UHFFFAOYSA-N 0.000 description 2
- PTAPBGKYBVWNJY-UHFFFAOYSA-N 2,3-dibenzoyl-2,3-dihydroxybutanedioic acid;hydrate Chemical compound O.C=1C=CC=CC=1C(=O)C(O)(C(O)=O)C(O)(C(=O)O)C(=O)C1=CC=CC=C1 PTAPBGKYBVWNJY-UHFFFAOYSA-N 0.000 description 2
- OZJQBLPOUXJQBT-UHFFFAOYSA-N 2-[(2-methoxyphenyl)sulfanylmethyl]prop-2-enoic acid Chemical compound COC1=CC=CC=C1SCC(=C)C(O)=O OZJQBLPOUXJQBT-UHFFFAOYSA-N 0.000 description 2
- YNBYUOIJSQNJAU-UHFFFAOYSA-N 2-[1-amino-6-(4-methoxyphenoxy)hex-4-ynyl]isoindole-1,3-dione Chemical compound C1=CC(OC)=CC=C1OCC#CCCC(N)N1C(=O)C2=CC=CC=C2C1=O YNBYUOIJSQNJAU-UHFFFAOYSA-N 0.000 description 2
- HUMVLYMVTCKMKW-UHFFFAOYSA-N 2-[3-(6-methoxy-2h-chromen-4-yl)propyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCCC1=CCOC2=CC=C(OC)C=C21 HUMVLYMVTCKMKW-UHFFFAOYSA-N 0.000 description 2
- SRZGGSBAAWJSLJ-UHFFFAOYSA-N 3-(6-methoxy-2h-chromen-4-yl)propan-1-amine;hydrochloride Chemical compound Cl.O1CC=C(CCCN)C2=CC(OC)=CC=C21 SRZGGSBAAWJSLJ-UHFFFAOYSA-N 0.000 description 2
- OFKWWALNMPEOSZ-UHFFFAOYSA-N 3-(hydrazinylmethyl)phenol Chemical compound NNCC1=CC=CC(O)=C1 OFKWWALNMPEOSZ-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- LSXWOUFGIJEZPT-UHFFFAOYSA-N 5H-chromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.C1=C2C(=NC=C1)COC1=C2C=CC=C1 LSXWOUFGIJEZPT-UHFFFAOYSA-N 0.000 description 2
- LMCDFCKWRNBXBB-UHFFFAOYSA-N 6-methoxy-2h-chromene Chemical compound O1CC=CC2=CC(OC)=CC=C21 LMCDFCKWRNBXBB-UHFFFAOYSA-N 0.000 description 2
- WLORISMINQWNAH-UHFFFAOYSA-N 7-methoxy-3,4,4a,5-tetrahydro-2h-chromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C12=CCCNC2COC2=C1C=CC=C2OC WLORISMINQWNAH-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- UCLKKLUJRBIKDA-UHFFFAOYSA-N 8-methoxy-3,4-dihydro-2h-thiochromene-3-carboxylic acid Chemical compound C1C(C(O)=O)CSC2=C1C=CC=C2OC UCLKKLUJRBIKDA-UHFFFAOYSA-N 0.000 description 2
- UPBSICACNAVTFQ-UHFFFAOYSA-N 8-methoxy-4h-thiochromen-3-one Chemical compound C1C(=O)CSC2=C1C=CC=C2OC UPBSICACNAVTFQ-UHFFFAOYSA-N 0.000 description 2
- BIUIHARSPSMXIO-UHFFFAOYSA-N 9-methoxy-3,4,4a,5-tetrahydro-2h-chromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.N1CCC=C2C3=CC(OC)=CC=C3OCC21 BIUIHARSPSMXIO-UHFFFAOYSA-N 0.000 description 2
- BYTDMYLHLQZNGX-UHFFFAOYSA-N 9-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine Chemical compound C1=C(OC)C=C2C3CCCN(CCC)C3COC2=C1 BYTDMYLHLQZNGX-UHFFFAOYSA-N 0.000 description 2
- AMJNIVMTWXCNPF-UHFFFAOYSA-N 9-methoxy-4-propyl-2,3,4a,5-tetrahydrothiochromeno[3,4-b]pyridine Chemical compound C1=C(OC)C=C2C3=CCCN(CCC)C3CSC2=C1 AMJNIVMTWXCNPF-UHFFFAOYSA-N 0.000 description 2
- DKPQETYUPDCFFR-UHFFFAOYSA-N 9-methoxy-4-propyl-2,5-dihydro-1h-chromeno[3,4-b]pyridin-3-one Chemical compound C1OC2=CC=C(OC)C=C2C2=C1N(CCC)C(=O)CC2 DKPQETYUPDCFFR-UHFFFAOYSA-N 0.000 description 2
- PCWKRKHCQKZFEH-UHFFFAOYSA-N 9-methoxy-4-propyl-3,5-dihydro-2h-chromeno[3,4-b]pyridin-1-one Chemical compound C1OC2=CC=C(OC)C=C2C2=C1N(CCC)CCC2=O PCWKRKHCQKZFEH-UHFFFAOYSA-N 0.000 description 2
- BWOPQLOGUSKENM-UHFFFAOYSA-N 9-methoxy-4-propyl-3,5-dihydro-2h-thiochromeno[3,4-b]pyridin-1-one Chemical compound C1SC2=CC=C(OC)C=C2C2=C1N(CCC)CCC2=O BWOPQLOGUSKENM-UHFFFAOYSA-N 0.000 description 2
- VAMBCEUSMVVGKH-UHFFFAOYSA-N 9-methoxy-4-propyl-4a,5-dihydro-3h-chromeno[3,4-b]pyridin-2-one Chemical compound C1=C(OC)C=C2C3=CC(=O)CN(CCC)C3COC2=C1 VAMBCEUSMVVGKH-UHFFFAOYSA-N 0.000 description 2
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 101100072790 Mus musculus Irf4 gene Proteins 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- OYLQPSZJXLEPQK-OVAHNPOGSA-N [(4aS,10bR)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-9-yl] benzoate hydrochloride Chemical compound Cl.C([C@@H]1[C@@H](C2=C3)CCCN1CCC)OC2=CC=C3OC(=O)C1=CC=CC=C1 OYLQPSZJXLEPQK-OVAHNPOGSA-N 0.000 description 2
- VFNIQQPDWRLLBH-UKRRQHHQSA-N [(4as,10br)-7-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-8-yl]methanol Chemical compound C1=CC(CO)=C(OC)C2=C1[C@H]1CCCN(CCC)[C@@H]1CO2 VFNIQQPDWRLLBH-UKRRQHHQSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 125000005336 allyloxy group Chemical group 0.000 description 2
- 102000030484 alpha-2 Adrenergic Receptor Human genes 0.000 description 2
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 230000000561 anti-psychotic effect Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 230000005978 brain dysfunction Effects 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052987 metal hydride Inorganic materials 0.000 description 2
- 150000004681 metal hydrides Chemical class 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000001242 postsynaptic effect Effects 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000004089 psychotropic agent Substances 0.000 description 2
- 201000000980 schizophrenia Diseases 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000952 serotonin receptor agonist Substances 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 2
- KJDOPAARIYGENL-YNDBEVAQSA-N (2r,4ar)-2-ethyl-9-methoxy-4-propyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C1=C(OC)C=C2C3=C[C@@H](CC)CN(CCC)[C@H]3COC2=C1 KJDOPAARIYGENL-YNDBEVAQSA-N 0.000 description 1
- GTFNIPOKNNRTQM-MFKMUULPSA-N (2r,4ar)-7-methoxy-2,4-dimethyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine Chemical compound C12=C[C@@H](C)CN(C)[C@H]2COC2=C1C=CC=C2OC GTFNIPOKNNRTQM-MFKMUULPSA-N 0.000 description 1
- HNKUIICIHKSCLA-WBMJQRKESA-N (2r,4ar)-9-methoxy-2-methyl-4-propyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine Chemical compound C1=C(OC)C=C2C3=C[C@@H](C)CN(CCC)[C@H]3COC2=C1 HNKUIICIHKSCLA-WBMJQRKESA-N 0.000 description 1
- MDVPTCKSYFJQIY-WBMJQRKESA-N (2r,4ar)-n-tert-butyl-9-methoxy-4-methyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine-2-carboxamide Chemical compound CN1C[C@H](C(=O)NC(C)(C)C)C=C2C3=CC(OC)=CC=C3OC[C@@H]21 MDVPTCKSYFJQIY-WBMJQRKESA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- AOZIAMAGVPEFBZ-UHFFFAOYSA-N (4-propyl-1,2,3,4a,5,10b-hexahydrothiochromeno[3,4-b]pyridin-9-yl) acetate hydrochloride Chemical compound Cl.C1=C(OC(C)=O)C=C2C3CCCN(CCC)C3CSC2=C1 AOZIAMAGVPEFBZ-UHFFFAOYSA-N 0.000 description 1
- BDUMPLZHKLPNEV-UHFFFAOYSA-N (4-propyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridin-9-yl) benzoate Chemical compound CCCN1CCC=C(C2=C3)C1COC2=CC=C3OC(=O)C1=CC=CC=C1 BDUMPLZHKLPNEV-UHFFFAOYSA-N 0.000 description 1
- TWCVYACMBPUKEE-UHFFFAOYSA-N (4-propyl-2,3,4a,5-tetrahydrothiochromeno[3,4-b]pyridin-9-yl) benzoate;hydrochloride Chemical compound Cl.CCCN1CCC=C(C2=C3)C1CSC2=CC=C3OC(=O)C1=CC=CC=C1 TWCVYACMBPUKEE-UHFFFAOYSA-N 0.000 description 1
- HSKSTQXBMFSQKP-ZVWHLABXSA-N (4aS,10bR)-10-methoxy-4,8-dimethyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.COC1=CC(=CC2=C1[C@@H]1[C@H](N(CCC1)C)CO2)C HSKSTQXBMFSQKP-ZVWHLABXSA-N 0.000 description 1
- MYROEACLNNRBBC-LMRHVHIWSA-N (4aS,10bR)-10-methoxy-8-methyl-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.COC1=CC(=CC2=C1[C@@H]1[C@H](N(CCC1)CCC)CO2)C MYROEACLNNRBBC-LMRHVHIWSA-N 0.000 description 1
- GRVXDJZRHHDISL-GRTNUQQKSA-N (4aS,10bR)-10-phenylmethoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.C(C1=CC=CC=C1)OC1=CC=CC2=C1[C@@H]1[C@H](N(CCC1)CCC)CO2 GRVXDJZRHHDISL-GRTNUQQKSA-N 0.000 description 1
- YSEHOGXOGODACA-GBNZRNLASA-N (4aS,10bR)-10b-ethyl-4-propyl-2,3,4a,5-tetrahydro-1H-chromeno[3,4-b]pyridin-9-ol hydrochloride Chemical compound Cl.C(C)[C@@]12[C@H](N(CCC1)CCC)COC1=C2C=C(C=C1)O YSEHOGXOGODACA-GBNZRNLASA-N 0.000 description 1
- FIJZFEIABPXXPX-GHXDPTCOSA-N (4aS,10bR)-2,3,4,4a,5,10b-hexahydro-1H-chromeno[3,4-b]pyridin-7-ol hydrochloride Chemical compound Cl.C([C@@H]12)CCN[C@@H]1COC1=C2C=CC=C1O FIJZFEIABPXXPX-GHXDPTCOSA-N 0.000 description 1
- BHZQUTAOQNKRPW-SWYZXDRTSA-N (4aS,10bR)-4-butyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.C(CCC)N1[C@H]2[C@H](CCC1)C1=C(OC2)C=CC=C1 BHZQUTAOQNKRPW-SWYZXDRTSA-N 0.000 description 1
- LVLSPLKPVUQOFX-BAUSSPIASA-N (4aS,10bR)-4-methyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-10-ol hydrochloride Chemical compound Cl.CN1[C@H]2[C@H](CCC1)C1=C(OC2)C=CC=C1O LVLSPLKPVUQOFX-BAUSSPIASA-N 0.000 description 1
- MVUOPIBAOLRTGO-FOKYBFFNSA-N (4aS,10bR)-4-methyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-7-ol hydrochloride Chemical compound Cl.C1=CC=C2[C@H]3CCCN(C)[C@@H]3COC2=C1O MVUOPIBAOLRTGO-FOKYBFFNSA-N 0.000 description 1
- AXHIMRLPSDPPMD-MHDYBILJSA-N (4aS,10bR)-4-methyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-9-ol hydrochloride Chemical compound Cl.C1=C(O)C=C2[C@H]3CCCN(C)[C@@H]3COC2=C1 AXHIMRLPSDPPMD-MHDYBILJSA-N 0.000 description 1
- XQAFSKONSDIVPR-MCJVGQIASA-N (4aS,10bR)-4-methyl-10-phenylmethoxy-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.C(C1=CC=CC=C1)OC1=CC=CC2=C1[C@@H]1[C@H](N(CCC1)C)CO2 XQAFSKONSDIVPR-MCJVGQIASA-N 0.000 description 1
- WZAXPZGLXKWAHH-ZVWHLABXSA-N (4aS,10bR)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-10-ol hydrochloride Chemical compound Cl.OC1=CC=CC2=C1[C@@H]1[C@H](N(CCC1)CCC)CO2 WZAXPZGLXKWAHH-ZVWHLABXSA-N 0.000 description 1
- NZKVPXXYGXKISU-QMDUSEKHSA-N (4aS,10bR)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-8-ol hydrochloride Chemical compound Cl.OC1=CC=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 NZKVPXXYGXKISU-QMDUSEKHSA-N 0.000 description 1
- WOUAPBBJJIYAAV-MHDYBILJSA-N (4aS,10bR)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine-8,9-diol hydrochloride Chemical compound Cl.OC1=C(O)C=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 WOUAPBBJJIYAAV-MHDYBILJSA-N 0.000 description 1
- AKRZLNBTVCDMQQ-STEACBGWSA-N (4aS,10bR)-7-bromo-10-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound CCCN1CCC[C@H]2[C@H]1COC3=C(C=CC(=C23)OC)Br.Cl AKRZLNBTVCDMQQ-STEACBGWSA-N 0.000 description 1
- PWDBLPOOXMXWDI-UKRRQHHQSA-N (4aS,10bR)-7-methoxy-4,10b-dimethyl-4a,5-dihydro-3H-chromeno[3,4-b]pyridine Chemical compound CN([C@@H]1CO2)CC=C[C@]1(C)C1=C2C(OC)=CC=C1 PWDBLPOOXMXWDI-UKRRQHHQSA-N 0.000 description 1
- IGFCCWGZPOAMES-MHDYBILJSA-N (4aS,10bR)-7-methoxy-4-methyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.C([C@@H]12)CCN(C)[C@@H]1COC1=C2C=CC=C1OC IGFCCWGZPOAMES-MHDYBILJSA-N 0.000 description 1
- BTIOCRGPOYSNCF-LMRHVHIWSA-N (4aS,10bR)-7-methoxy-4-methyl-10-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.COC1=CC=C(C2=C1OC[C@H]1N(CCC[C@@H]12)C)CCC BTIOCRGPOYSNCF-LMRHVHIWSA-N 0.000 description 1
- VBMCSBZTWRPQLO-TZMCWYRMSA-N (4aS,10bR)-7-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine Chemical compound C1=CC=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1OC VBMCSBZTWRPQLO-TZMCWYRMSA-N 0.000 description 1
- UZGFPDYZPIVJFW-SWYZXDRTSA-N (4aS,10bR)-7-methoxy-8-methyl-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.COC1=C(C=CC2=C1OC[C@H]1N(CCC[C@@H]12)CCC)C UZGFPDYZPIVJFW-SWYZXDRTSA-N 0.000 description 1
- GZFKXWAXTWUFIL-LDYMZIIASA-N (4aS,10bR)-8-bromo-4-methyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-7-ol Chemical compound BrC1=C(C2=C(C=C1)[C@@H]1[C@H](N(CCC1)C)CO2)O GZFKXWAXTWUFIL-LDYMZIIASA-N 0.000 description 1
- IWVVMTZNHVBMCZ-GBWFEORMSA-N (4aS,10bR)-8-bromo-7-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.BrC1=C(C2=C(C=C1)[C@@H]1[C@H](N(CCC1)CCC)CO2)OC IWVVMTZNHVBMCZ-GBWFEORMSA-N 0.000 description 1
- VYFSUQGIKMMIFV-LDXVYITESA-N (4aS,10bR)-8-ethyl-10-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine hydrochloride Chemical compound Cl.C(C)C1=CC2=C(C(=C1)OC)[C@@H]1[C@H](N(CCC1)CCC)CO2 VYFSUQGIKMMIFV-LDXVYITESA-N 0.000 description 1
- VOXPPRUHELNHGW-JHEYCYPBSA-N (4aS,10bR)-8-methyl-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-10-ol hydrochloride Chemical compound CCCN1CCC[C@H]2[C@H]1COC3=CC(=CC(=C23)O)C.Cl VOXPPRUHELNHGW-JHEYCYPBSA-N 0.000 description 1
- MBTKFRMZPJKSSW-GDBMZVCRSA-N (4aS,10bR)-9-ethoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine Chemical compound C1=C(OCC)C=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 MBTKFRMZPJKSSW-GDBMZVCRSA-N 0.000 description 1
- IIARBXRSECAIPI-JHEYCYPBSA-N (4as,10br)-10-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C1=CC(OC)=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 IIARBXRSECAIPI-JHEYCYPBSA-N 0.000 description 1
- NFFXBIFHJDFPLH-JHEYCYPBSA-N (4as,10br)-4-methyl-10-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-7-ol;hydrochloride Chemical compound Cl.C1=2C(CCC)=CC=C(O)C=2OC[C@@H]2[C@@H]1CCCN2C NFFXBIFHJDFPLH-JHEYCYPBSA-N 0.000 description 1
- GSLWRDKYYIQKIM-TZMCWYRMSA-N (4as,10br)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-9-ol Chemical compound C1=C(O)C=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 GSLWRDKYYIQKIM-TZMCWYRMSA-N 0.000 description 1
- ITPJYEUURUKXLG-MWLCHTKSSA-N (4as,10br)-7-methoxy-2,3,4,4a,5,10b-hexahydro-1h-chromeno[3,4-b]pyridine Chemical compound C([C@@H]12)CCN[C@@H]1COC1=C2C=CC=C1OC ITPJYEUURUKXLG-MWLCHTKSSA-N 0.000 description 1
- LCEHNJRPLNXHKI-FOKYBFFNSA-N (4as,10br)-7-methoxy-2,3,4,4a,5,10b-hexahydro-1h-chromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C([C@@H]12)CCN[C@@H]1COC1=C2C=CC=C1OC LCEHNJRPLNXHKI-FOKYBFFNSA-N 0.000 description 1
- SOFNKTGALNTLEI-MRYVXRNOSA-N (4as,10br)-8-(hydroxymethyl)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-7-ol;(e)-but-2-enedioic acid Chemical compound OC(=O)\C=C\C(O)=O.OCC1=CC=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1O SOFNKTGALNTLEI-MRYVXRNOSA-N 0.000 description 1
- XTOMIMBNOLYVFG-WYUVZMMLSA-N (4as,10br)-8-bromo-7-methoxy-4-methyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C([C@@H]12)CCN(C)[C@@H]1COC1=C2C=CC(Br)=C1OC XTOMIMBNOLYVFG-WYUVZMMLSA-N 0.000 description 1
- AKHQSFYZFIDYFS-BXUZGUMPSA-N (4as,10br)-8-bromo-7-methoxy-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridine Chemical compound C1=CC(Br)=C(OC)C2=C1[C@H]1CCCN(CCC)[C@@H]1CO2 AKHQSFYZFIDYFS-BXUZGUMPSA-N 0.000 description 1
- 125000005862 (C1-C6)alkanoyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- WLXGQMVCYPUOLM-UHFFFAOYSA-N 1-hydroxyethanesulfonic acid Chemical class CC(O)S(O)(=O)=O WLXGQMVCYPUOLM-UHFFFAOYSA-N 0.000 description 1
- ULDZDSQQHOLKDH-UHFFFAOYSA-N 1-methoxy-2-prop-2-ynoxybenzene Chemical compound COC1=CC=CC=C1OCC#C ULDZDSQQHOLKDH-UHFFFAOYSA-N 0.000 description 1
- YRHCGFRCOATEFD-UHFFFAOYSA-N 1-methoxy-4-prop-2-ynoxybenzene Chemical compound COC1=CC=C(OCC#C)C=C1 YRHCGFRCOATEFD-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- MTXPEOIBVAYNHQ-UHFFFAOYSA-N 10-methoxy-4,8-dimethyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.O1CC2N(C)CCC=C2C2=C1C=C(C)C=C2OC MTXPEOIBVAYNHQ-UHFFFAOYSA-N 0.000 description 1
- DITBRIJGIQYVOS-UHFFFAOYSA-N 10-methoxy-4-methyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.O1CC2N(C)CCC=C2C2=C1C=CC=C2OC DITBRIJGIQYVOS-UHFFFAOYSA-N 0.000 description 1
- VYCVNNQMHZAPHP-UHFFFAOYSA-N 10-methoxy-4-propyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C1=CC(OC)=C2C3=CCCN(CCC)C3COC2=C1 VYCVNNQMHZAPHP-UHFFFAOYSA-N 0.000 description 1
- CVQSWZMJOGOPAV-UHFFFAOYSA-N 2,3-dihydrothiochromen-4-one Chemical compound C1=CC=C2C(=O)CCSC2=C1 CVQSWZMJOGOPAV-UHFFFAOYSA-N 0.000 description 1
- FKFJGKUATZGIRM-UHFFFAOYSA-N 2-(methylaminomethyl)butanoic acid Chemical compound CCC(C(O)=O)CNC FKFJGKUATZGIRM-UHFFFAOYSA-N 0.000 description 1
- DSCJETUEDFKYGN-UHFFFAOYSA-N 2-Methoxybenzenethiol Chemical compound COC1=CC=CC=C1S DSCJETUEDFKYGN-UHFFFAOYSA-N 0.000 description 1
- MGOLNIXAPIAKFM-UHFFFAOYSA-N 2-isocyanato-2-methylpropane Chemical compound CC(C)(C)N=C=O MGOLNIXAPIAKFM-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- VJSGGZIOWMCQRZ-UHFFFAOYSA-N 3-(2h-chromen-4-yl)propan-1-amine Chemical compound C1=CC=C2C(CCCN)=CCOC2=C1 VJSGGZIOWMCQRZ-UHFFFAOYSA-N 0.000 description 1
- STSPZWBTXUTPDT-UHFFFAOYSA-N 3-(3-bromo-6-methoxy-2,3-dihydrochromen-4-ylidene)propan-1-amine Chemical compound O1CC(Br)C(=CCCN)C2=CC(OC)=CC=C21 STSPZWBTXUTPDT-UHFFFAOYSA-N 0.000 description 1
- BHDMRLVPNMYDKS-UHFFFAOYSA-N 3-(3-bromo-8-methoxy-2,3-dihydrochromen-4-ylidene)propan-1-amine Chemical compound NCCC=C1C(Br)COC2=C1C=CC=C2OC BHDMRLVPNMYDKS-UHFFFAOYSA-N 0.000 description 1
- GTCPICGSNVLJIN-UHFFFAOYSA-N 3-(8-methoxy-2h-chromen-4-yl)propan-1-amine;hydrochloride Chemical compound Cl.NCCCC1=CCOC2=C1C=CC=C2OC GTCPICGSNVLJIN-UHFFFAOYSA-N 0.000 description 1
- IJKHVVXXNCBXAW-UHFFFAOYSA-N 3-(butylamino)-2-methylpropanoic acid Chemical compound CCCCNCC(C)C(O)=O IJKHVVXXNCBXAW-UHFFFAOYSA-N 0.000 description 1
- RECBXYAULJFBPT-UHFFFAOYSA-N 3-bromo-6-methoxy-2,3-dihydrochromen-4-one Chemical compound O1CC(Br)C(=O)C2=CC(OC)=CC=C21 RECBXYAULJFBPT-UHFFFAOYSA-N 0.000 description 1
- QDNVQQPKBRGLSF-UHFFFAOYSA-N 3-chloro-n-propylpropan-1-amine Chemical compound CCCNCCCCl QDNVQQPKBRGLSF-UHFFFAOYSA-N 0.000 description 1
- MSTDXOZUKAQDRL-UHFFFAOYSA-N 4-Chromanone Chemical class C1=CC=C2C(=O)CCOC2=C1 MSTDXOZUKAQDRL-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 1
- GIOXAXLDHLFTTI-UHFFFAOYSA-N 4-butyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C1=CC=C2C3=CCCN(CCCC)C3COC2=C1 GIOXAXLDHLFTTI-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- WKTOVVRMXMETTI-UHFFFAOYSA-N 4-methyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridin-7-ol;hydrochloride Chemical compound Cl.C1=CC=C2C3=CCCN(C)C3COC2=C1O WKTOVVRMXMETTI-UHFFFAOYSA-N 0.000 description 1
- YGPQPOSWWCIIKP-UHFFFAOYSA-N 4-methyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridin-9-ol;hydrochloride Chemical compound Cl.C1=C(O)C=C2C3=CCCN(C)C3COC2=C1 YGPQPOSWWCIIKP-UHFFFAOYSA-N 0.000 description 1
- PTXAGVWPMKLYMK-UHFFFAOYSA-N 4-methyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C1=CC=C2C3=CCCN(C)C3COC2=C1 PTXAGVWPMKLYMK-UHFFFAOYSA-N 0.000 description 1
- WKNQXQHUNTVKLL-UHFFFAOYSA-N 4-propyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridin-7-ol;hydrochloride Chemical compound Cl.C1=CC=C2C3=CCCN(CCC)C3COC2=C1O WKNQXQHUNTVKLL-UHFFFAOYSA-N 0.000 description 1
- ZIAAXJKVFPQCSO-UHFFFAOYSA-N 4-propyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine-8,9-diol;hydrochloride Chemical compound Cl.OC1=C(O)C=C2C3=CCCN(CCC)C3COC2=C1 ZIAAXJKVFPQCSO-UHFFFAOYSA-N 0.000 description 1
- CBTAOALUXSREAM-UHFFFAOYSA-N 4-propyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C1=CC=C2C3=CCCN(CCC)C3COC2=C1 CBTAOALUXSREAM-UHFFFAOYSA-N 0.000 description 1
- WCZLKVGKLDVNKQ-UHFFFAOYSA-N 4-propyl-2,3,4a,5-tetrahydrothiochromeno[3,4-b]pyridin-9-ol;hydrochloride Chemical compound Cl.C1=C(O)C=C2C3=CCCN(CCC)C3CSC2=C1 WCZLKVGKLDVNKQ-UHFFFAOYSA-N 0.000 description 1
- SYHZXVJJXMLSAR-UHFFFAOYSA-N 4-propyl-2,3,4a,5-tetrahydrothiochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C1=CC=C2C3=CCCN(CCC)C3CSC2=C1 SYHZXVJJXMLSAR-UHFFFAOYSA-N 0.000 description 1
- KNTIRDWFHBETOO-UHFFFAOYSA-N 4h-chromeno[3,4-b]pyridine Chemical compound C1=CC=C2C3=CC=CNC3=COC2=C1 KNTIRDWFHBETOO-UHFFFAOYSA-N 0.000 description 1
- BXSPQBOQCWIFMX-UHFFFAOYSA-N 4h-thiochromeno[3,4-b]pyridine Chemical class C1=CC=C2C3=CC=CNC3=CSC2=C1 BXSPQBOQCWIFMX-UHFFFAOYSA-N 0.000 description 1
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 1
- 229940000681 5-hydroxytryptophan Drugs 0.000 description 1
- FLEAOKWALBNALM-UHFFFAOYSA-N 6-methoxy-4h-thiochromen-3-one Chemical compound S1CC(=O)CC2=CC(OC)=CC=C21 FLEAOKWALBNALM-UHFFFAOYSA-N 0.000 description 1
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
- AREBKWFDOIMSRG-UHFFFAOYSA-N 7-methoxy-2,4-dimethyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C12=CC(C)CN(C)C2COC2=C1C=CC=C2OC AREBKWFDOIMSRG-UHFFFAOYSA-N 0.000 description 1
- MRGKVNWENRRQCT-UHFFFAOYSA-N 7-methoxy-4-methyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C12=CCCN(C)C2COC2=C1C=CC=C2OC MRGKVNWENRRQCT-UHFFFAOYSA-N 0.000 description 1
- HHLVCGFUAICTEO-UHFFFAOYSA-N 7-methoxy-4-propyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine Chemical compound C1=CC=C2C3=CCCN(CCC)C3COC2=C1OC HHLVCGFUAICTEO-UHFFFAOYSA-N 0.000 description 1
- JPLNFRWFFWITOC-UHFFFAOYSA-N 7-methoxy-4-propyl-2,3,4a,5-tetrahydrothiochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C1=CC=C2C3=CCCN(CCC)C3CSC2=C1OC JPLNFRWFFWITOC-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- RETVOONTWYFZIS-UHFFFAOYSA-N 8-methoxy-2h-chromene Chemical compound C1=CCOC2=C1C=CC=C2OC RETVOONTWYFZIS-UHFFFAOYSA-N 0.000 description 1
- ZZIGLKVMEBXWJH-UHFFFAOYSA-N 8-methoxy-4,10-dimethyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine;hydrochloride Chemical compound Cl.C1CN(C)C2COC3=CC(OC)=CC(C)=C3C2=C1 ZZIGLKVMEBXWJH-UHFFFAOYSA-N 0.000 description 1
- BDMFZYRKPUWUHE-UHFFFAOYSA-N 9-methoxy-1,2,4,5-tetrahydrochromeno[3,4-b]pyridin-3-one Chemical compound C12=CC(OC)=CC=C2OCC2=C1CCC(=O)N2 BDMFZYRKPUWUHE-UHFFFAOYSA-N 0.000 description 1
- ODUMGSVRAHLVDM-UHFFFAOYSA-N 9-methoxy-2,3,4,4a,5,10b-hexahydro-1h-chromeno[3,4-b]pyridine Chemical compound N1CCCC2C3=CC(OC)=CC=C3OCC21 ODUMGSVRAHLVDM-UHFFFAOYSA-N 0.000 description 1
- FSLLOILNIQGMQR-UHFFFAOYSA-N 9-methoxy-4-methyl-2,3,4a,5-tetrahydrochromeno[3,4-b]pyridine Chemical compound CN1CCC=C2C3=CC(OC)=CC=C3OCC21 FSLLOILNIQGMQR-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 102000007527 Autoreceptors Human genes 0.000 description 1
- 108010071131 Autoreceptors Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ADFTWMSFYOFXTG-TZIWHRDSSA-N C([C@@H]1[C@@H](C2=C3)CCCN1CCC)OC2=CC=C3OCC1=CC=CC=C1 Chemical compound C([C@@H]1[C@@H](C2=C3)CCCN1CCC)OC2=CC=C3OCC1=CC=CC=C1 ADFTWMSFYOFXTG-TZIWHRDSSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- WXENTQACFYTYOX-QMDUSEKHSA-N Cl.C(C)C1=C(C2=C(C=C1)[C@@H]1[C@H](N(CCC1)C)CO2)OC Chemical compound Cl.C(C)C1=C(C2=C(C=C1)[C@@H]1[C@H](N(CCC1)C)CO2)OC WXENTQACFYTYOX-QMDUSEKHSA-N 0.000 description 1
- WZQZXLQUUBZMEO-CMXBXVFLSA-N Cl.C(C1=CC=CC=C1)OC1=CC(=CC2=C1[C@@H]1[C@H](N(CCC1)CCC)CO2)C Chemical compound Cl.C(C1=CC=CC=C1)OC1=CC(=CC2=C1[C@@H]1[C@H](N(CCC1)CCC)CO2)C WZQZXLQUUBZMEO-CMXBXVFLSA-N 0.000 description 1
- LGZQVMBBPFQBKL-QMDUSEKHSA-N Cl.C(CC)N1[C@H]2[C@H](CCC1)C1=C(SC2)C=CC=C1 Chemical compound Cl.C(CC)N1[C@H]2[C@H](CCC1)C1=C(SC2)C=CC=C1 LGZQVMBBPFQBKL-QMDUSEKHSA-N 0.000 description 1
- MFCLDQSHGBSETM-QMDUSEKHSA-N Cl.C1=C(O)C=C2[C@H]3CCCN(CCC)[C@@H]3CSC2=C1 Chemical compound Cl.C1=C(O)C=C2[C@H]3CCCN(CCC)[C@@H]3CSC2=C1 MFCLDQSHGBSETM-QMDUSEKHSA-N 0.000 description 1
- XYPURVGNAYMFTN-LOCPCMAASA-N Cl.C1=CC=C2[C@H]3CCCN(CCC)[C@@H]3CSC2=C1O Chemical compound Cl.C1=CC=C2[C@H]3CCCN(CCC)[C@@H]3CSC2=C1O XYPURVGNAYMFTN-LOCPCMAASA-N 0.000 description 1
- XBHOVQLJCDUKPU-MHDYBILJSA-N Cl.CC1=CC=C2[C@H]3CCCN(C)[C@@H]3COC2=C1O Chemical compound Cl.CC1=CC=C2[C@H]3CCCN(C)[C@@H]3COC2=C1O XBHOVQLJCDUKPU-MHDYBILJSA-N 0.000 description 1
- LRIDIMJZEKCLHW-SWYZXDRTSA-N Cl.COC1=C(C=CC2=C1OC[C@H]1N(CCC[C@@H]12)C)CCC Chemical compound Cl.COC1=C(C=CC2=C1OC[C@H]1N(CCC[C@@H]12)C)CCC LRIDIMJZEKCLHW-SWYZXDRTSA-N 0.000 description 1
- KIHFFINCXFGABP-UHFFFAOYSA-N Cl.[I] Chemical compound Cl.[I] KIHFFINCXFGABP-UHFFFAOYSA-N 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 229940081615 DOPA decarboxylase inhibitor Drugs 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical group C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical class O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- CQYUCMTWTJPSED-SSPJITILSA-N [(4aS,10bR)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-9-yl] 2,2-dimethylpropanoate hydrochloride Chemical compound Cl.C1=C(OC(=O)C(C)(C)C)C=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 CQYUCMTWTJPSED-SSPJITILSA-N 0.000 description 1
- VPKYVQZLUSUFMI-VNYZMKMESA-N [(4aS,10bR)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-9-yl] acetate hydrochloride Chemical compound Cl.C1=C(OC(C)=O)C=C2[C@H]3CCCN(CCC)[C@@H]3COC2=C1 VPKYVQZLUSUFMI-VNYZMKMESA-N 0.000 description 1
- QJTAAHJJXWYZSK-UHFFFAOYSA-N [Br].CC(O)=O Chemical compound [Br].CC(O)=O QJTAAHJJXWYZSK-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000384 adrenergic alpha-2 receptor agonist Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 1
- 239000003420 antiserotonin agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 150000008378 aryl ethers Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N beta-hydroxyethanesulfonic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical class C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- CDNRMYZZOFXKBW-UHFFFAOYSA-N chromeno[3,4-b]pyridin-5-one Chemical class C12=CC=CN=C2C(=O)OC2=C1C=CC=C2 CDNRMYZZOFXKBW-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical class C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- NTBIYBAYFBNTCD-UHFFFAOYSA-N dibenzoyl 2,3-dihydroxybutanedioate Chemical class C=1C=CC=CC=1C(=O)OC(=O)C(O)C(O)C(=O)OC(=O)C1=CC=CC=C1 NTBIYBAYFBNTCD-UHFFFAOYSA-N 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- YOTZYFSGUCFUKA-UHFFFAOYSA-N dimethylphosphine Chemical compound CPC YOTZYFSGUCFUKA-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000000534 dopa decarboxylase inhibitor Substances 0.000 description 1
- 229940052760 dopamine agonists Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical class CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- HQLZFBUAULNEGP-UHFFFAOYSA-N hexan-3-amine Chemical class CCCC(N)CC HQLZFBUAULNEGP-UHFFFAOYSA-N 0.000 description 1
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- XEAHDCXGDYQYIV-UHFFFAOYSA-N isochromeno[3,4-c]pyrrole Chemical class C1=CC=CC2=C3C=NC=C3OC=C21 XEAHDCXGDYQYIV-UHFFFAOYSA-N 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- FPCCSQOGAWCVBH-UHFFFAOYSA-N ketanserin Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(CCN2C(C3=CC=CC=C3NC2=O)=O)CC1 FPCCSQOGAWCVBH-UHFFFAOYSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- GDEQTSGNHQHPLZ-UHFFFAOYSA-N methyl 3-(propylamino)propanoate Chemical compound CCCNCCC(=O)OC GDEQTSGNHQHPLZ-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical class C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 150000004893 oxazines Chemical class 0.000 description 1
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000005544 phthalimido group Chemical class 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 230000001003 psychopharmacologic effect Effects 0.000 description 1
- 239000003368 psychostimulant agent Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- DKGZKTPJOSAWFA-UHFFFAOYSA-N spiperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 DKGZKTPJOSAWFA-UHFFFAOYSA-N 0.000 description 1
- 229950001675 spiperone Drugs 0.000 description 1
- 108010092215 spiroperidol receptor Proteins 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60903784A | 1984-05-10 | 1984-05-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUT37939A HUT37939A (en) | 1986-03-28 |
HU199476B true HU199476B (en) | 1990-02-28 |
Family
ID=24439108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU851751A HU199476B (en) | 1984-05-10 | 1985-05-09 | Process for producing benzopyrano /and -thiopyrano/ pyridines and pharmaceutical compositions comprising such compounds |
Country Status (20)
Country | Link |
---|---|
US (1) | US4604397A (en, 2012) |
EP (1) | EP0161218B1 (en, 2012) |
JP (1) | JPS60243090A (en, 2012) |
AR (1) | AR243526A1 (en, 2012) |
AT (1) | ATE64735T1 (en, 2012) |
AU (1) | AU592308B2 (en, 2012) |
CA (1) | CA1298582C (en, 2012) |
DD (1) | DD235872A5 (en, 2012) |
DE (1) | DE3583307D1 (en, 2012) |
DK (1) | DK168571B1 (en, 2012) |
ES (5) | ES8706687A1 (en, 2012) |
FI (1) | FI83652C (en, 2012) |
GR (1) | GR851116B (en, 2012) |
HU (1) | HU199476B (en, 2012) |
IE (1) | IE57978B1 (en, 2012) |
IL (1) | IL75135A (en, 2012) |
NO (1) | NO162860C (en, 2012) |
NZ (1) | NZ212031A (en, 2012) |
PT (1) | PT80415B (en, 2012) |
ZA (1) | ZA853507B (en, 2012) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8426584D0 (en) * | 1984-10-19 | 1984-11-28 | Beecham Group Plc | Compounds |
US4666916A (en) * | 1985-11-08 | 1987-05-19 | Ciba-Geigy Corporation | Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents |
US4792548A (en) * | 1986-05-21 | 1988-12-20 | Warner-Lambert Company | Trans-benzopyran-(4,3-b)-1,4-oxazine derivatives, intermediates and pharmaceutical use |
US4801605A (en) * | 1986-08-29 | 1989-01-31 | Ciba-Geigy Corporation | 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans |
FR2619112B1 (fr) * | 1987-08-07 | 1989-11-17 | Synthelabo | Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique |
US4992465A (en) * | 1988-09-27 | 1991-02-12 | Ciba-Geigy Corporation | 3-amino-dihydro-(1)-benzopyrans |
US5962463A (en) * | 1992-10-09 | 1999-10-05 | Massachusetts Institute Of Technology | Methods of stimulating non-amyloidogenic processing of the amyloid precursor protein |
FR2721027B1 (fr) | 1994-06-08 | 1996-07-19 | Adir | Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
FR2741074B1 (fr) | 1995-11-09 | 1997-12-19 | Adir | Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6342533B1 (en) * | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
EP1466889B1 (en) * | 1999-04-06 | 2008-06-04 | Sepracor Inc. | O-Desmethylvenlafaxine succinate |
WO2005032485A2 (en) * | 2003-10-03 | 2005-04-14 | Psychogenics, Inc. | Compounds and methods for the treatment of attention-deficit hyperactivity disorder |
AU2006265008A1 (en) * | 2005-07-06 | 2007-01-11 | Sepracor Inc. | Combinations of eszopiclone and O-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
BRPI1003506B1 (pt) | 2010-09-24 | 2019-12-03 | Ache Int Bvi Ltd | composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1143819A (en, 2012) * | 1965-09-27 | |||
US3514464A (en) * | 1967-05-29 | 1970-05-26 | Little Inc A | 5-oxo-1,2,3,4-tetrahydro-5h-(1)benzopyrano(3,4-c)pyridines |
US3689497A (en) * | 1971-03-09 | 1972-09-05 | Warner Lambert Co | Substituted benzopyrano (3,4-b) pyridines and process for their preparation |
US3915996A (en) * | 1972-10-16 | 1975-10-28 | Abbott Lab | Process for making benzopyrans |
US4025630A (en) * | 1973-09-19 | 1977-05-24 | Abbott Laboratories | Anesthesia methods using benzopyrans and esters thereof as pre-anesthesia medication |
US4292316A (en) * | 1978-10-02 | 1981-09-29 | Abbott Laboratories | Antiglaucoma agents |
US4210758A (en) * | 1979-03-21 | 1980-07-01 | Warner-Lambert Company | 1,5-Dihydro-1,5-dioxo-N-1H-tetrazol-5-yl-4H-[1]benzopyrano[3,4-b]pyridine-2-carboxamides |
US4198511A (en) * | 1979-03-21 | 1980-04-15 | Warner-Lambert Company | 1,5-Dihydro-1,5-dioxo-N-1H-tetrazol-5-yl-4H-[1]benzopyrano[3,4-b]pyridine-3-carboxamides and process thereof |
JPS5746903A (en) * | 1980-09-05 | 1982-03-17 | Mitsubishi Chem Ind Ltd | Agricultural and gardening fungicide |
NL8005754A (nl) * | 1980-10-18 | 1982-05-17 | Akzo Nv | Benzo 4,5 pyrano 2,3-c pyrrool derivaten. |
US4420480A (en) * | 1981-11-20 | 1983-12-13 | Merck & Co., Inc. | Hexahydronaphth[1,2-b]-1,4-oxazines |
US4540691A (en) * | 1984-04-13 | 1985-09-10 | Nelson Research & Development Co. | Dopamine agonists and use thereof |
US4666916A (en) * | 1985-11-08 | 1987-05-19 | Ciba-Geigy Corporation | Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents |
-
1985
- 1985-05-06 DE DE8585810208T patent/DE3583307D1/de not_active Expired - Lifetime
- 1985-05-06 AT AT85810208T patent/ATE64735T1/de not_active IP Right Cessation
- 1985-05-06 EP EP85810208A patent/EP0161218B1/de not_active Expired - Lifetime
- 1985-05-07 DD DD85276081A patent/DD235872A5/de not_active IP Right Cessation
- 1985-05-08 GR GR851116A patent/GR851116B/el unknown
- 1985-05-08 ES ES542929A patent/ES8706687A1/es not_active Expired
- 1985-05-08 CA CA000481003A patent/CA1298582C/en not_active Expired - Lifetime
- 1985-05-08 PT PT80415A patent/PT80415B/pt not_active IP Right Cessation
- 1985-05-08 IL IL75135A patent/IL75135A/xx unknown
- 1985-05-08 FI FI851802A patent/FI83652C/fi not_active IP Right Cessation
- 1985-05-09 HU HU851751A patent/HU199476B/hu not_active IP Right Cessation
- 1985-05-09 AU AU42248/85A patent/AU592308B2/en not_active Ceased
- 1985-05-09 IE IE1155/85A patent/IE57978B1/en not_active IP Right Cessation
- 1985-05-09 JP JP60096820A patent/JPS60243090A/ja active Granted
- 1985-05-09 NO NO851846A patent/NO162860C/no unknown
- 1985-05-09 NZ NZ212031A patent/NZ212031A/xx unknown
- 1985-05-09 DK DK205285A patent/DK168571B1/da not_active IP Right Cessation
- 1985-05-09 ZA ZA853507A patent/ZA853507B/xx unknown
- 1985-05-10 AR AR85300343A patent/AR243526A1/es active
- 1985-09-03 US US06/771,934 patent/US4604397A/en not_active Expired - Lifetime
-
1986
- 1986-05-30 ES ES555527A patent/ES8801279A1/es not_active Expired
- 1986-05-30 ES ES555529A patent/ES8801281A1/es not_active Expired
- 1986-05-30 ES ES555528A patent/ES8801280A1/es not_active Expired
- 1986-05-30 ES ES555530A patent/ES8801282A1/es not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI107918B (fi) | Menetelmä terapeuttisesti aktiivisten trisyklisten 1-aminoalkyylipyrrolijohdannaisten valmistamiseksi | |
DE69531998T2 (de) | Steroidrezeptor-modulator verbindungen und methoden | |
ES2246399T3 (es) | 1,2,3,4-tetrahidroisoquinolinas como antagonistas derivados del receptor de urotensina ii. | |
HU199476B (en) | Process for producing benzopyrano /and -thiopyrano/ pyridines and pharmaceutical compositions comprising such compounds | |
EP1212320B1 (en) | Phenylpiperazines as serotonin reuptake inhibitors | |
US4801605A (en) | 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans | |
CZ9502013A3 (en) | Tricyclic 1-amino ethylpyrazole derivatives, process and intermediates for their preparation and pharmaceutical compositions based thereon | |
US6124285A (en) | Indole-2,3-dione-3-oxime derivatives | |
JP2003524571A (ja) | インドール−及び2,3−ジヒドロインドール誘導体、その製造方法及びその使用方法 | |
AU596113B2 (en) | 3-Amino-dihydro-(1)-benzopyrans and benzothiopyrans | |
JPH0745470B2 (ja) | 6−置換−4−ジアルキルアミノテトラヒドロベンズ[c,dインドール類の合成中間体 | |
DE69829317T2 (de) | Tetrahydrobenzindol-derivate | |
RU2284325C2 (ru) | Производные фенил-3-аминометил-хинолона-2 в качестве ингибиторов no-синтетазы, способ их получения, биологически активные соединения и фармацевтическая композиция на их основе | |
CZ377498A3 (cs) | Hexahydropyrido (4,3-b) indolové deriváty jako antipsychotická léčiva | |
WO2006054912A1 (fr) | Derives d'aryl(hetaryl)-3-aminomethylchinolone-2 utilises en tant qu'inhibiteurs de no-synthetase et de cyclo-oxygenase-2, procedes de leur fabrication et compositions pharmaceutiques sur leur base | |
US20040024207A1 (en) | 8'4-'3-(5Fluoro-1h-indol-3yl)propyl!-1-piperazinyl!-2-methyl-2h-1,4-benzoxazin-3(4h)-one methanesulfonate with high affinity for the dopamine d2 receptor and the seotonix reuptake site | |
US4721787A (en) | Process for the preparation of benzo-(pyrano and thiopyrano)-pyridines | |
HU196409B (en) | Process for production of hexahidro-/1/-benzopirane and benzitiopirane /4,3-a/-piridine-derivatives and medical preparatives containg these substances | |
US4992465A (en) | 3-amino-dihydro-(1)-benzopyrans | |
AU2746902A (en) | New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them | |
EP0299101A1 (en) | Fused benzazepines | |
US5242918A (en) | Isatinoxime derivatives, their preparation and use | |
FI68225B (fi) | Foerfarande foer framstaellning av 6,7-benzomorfanderivat vilka aer anvaendbara som analgetiska medel antagonister foer nakotiska medel och inhibitorer foer sekretion av luteinise rigshormon | |
CA2035966A1 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HU90 | Patent valid on 900628 | ||
HMM4 | Cancellation of final prot. due to non-payment of fee |